MedTrace Logo

The OPTI Study in Spain Looks at the History Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Inhaled Steroids.

NCT03611777 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 901

Last updated 2021-04-08

Study results available
· View outcomes & findings →

Summary

This non-Interventional, descriptive, cross-sectional cohort and multicentre study will be conducted with COPD patients attended at Spanish Primary Care offices.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Inhaled corticosteroid

Drug

Sponsors & Collaborators

Principal Investigators

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-14
Primary Completion
2020-01-31
Completion
2020-01-31
FDA Drug
Yes

Countries

  • Spain

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03611777 on ClinicalTrials.gov